Release Date: 11/09/23 10:47 Summary: PDS dated 11 September 2023 Price Sensitive: No Download Document 856.02KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%